Farallon Capital Management as of Dec. 31, 2018
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 93 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 16.8 | $2.0B | 8.2M | 249.92 | |
| Altaba | 13.1 | $1.6B | 28M | 57.94 | |
| Alphabet Inc Class C cs (GOOG) | 4.0 | $481M | 464k | 1035.61 | |
| Facebook Inc cl a (META) | 3.3 | $400M | 3.1M | 131.09 | |
| Equinix (EQIX) | 3.2 | $392M | 1.1M | 352.56 | |
| Wabtec Corporation (WAB) | 3.2 | $389M | 5.5M | 70.25 | |
| Iqvia Holdings (IQV) | 3.1 | $374M | 3.2M | 116.17 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 2.5 | $308M | 1.1M | 284.97 | |
| Visa (V) | 2.5 | $306M | 2.3M | 131.94 | |
| Transunion (TRU) | 2.5 | $299M | 5.3M | 56.80 | |
| Booking Holdings (BKNG) | 2.3 | $285M | 166k | 1722.42 | |
| Ihs Markit | 2.3 | $284M | 5.9M | 47.97 | |
| Anthem (ELV) | 2.3 | $276M | 1.1M | 262.63 | |
| Microsoft Corporation (MSFT) | 2.2 | $263M | 2.6M | 101.57 | |
| General Dynamics Corporation (GD) | 2.1 | $256M | 1.6M | 157.21 | |
| Playa Hotels & Resorts Nv (PLYA) | 1.8 | $220M | 31M | 7.19 | |
| Equifax (EFX) | 1.6 | $200M | 2.1M | 93.13 | |
| Cigna Corp (CI) | 1.6 | $200M | 1.1M | 189.92 | |
| Fidelity National Information Services (FIS) | 1.6 | $195M | 1.9M | 102.55 | |
| Vaneck Vectors Semiconductor Etf semiconductor (SMH) | 1.5 | $188M | 2.2M | 87.28 | |
| Dell Technologies (DELL) | 1.4 | $175M | 3.6M | 48.87 | |
| Tilray (TLRY) | 1.3 | $162M | 2.5M | 65.37 | |
| Verisk Analytics (VRSK) | 1.3 | $157M | 1.4M | 109.04 | |
| Citrix Systems | 1.2 | $150M | 1.5M | 102.46 | |
| AstraZeneca (AZN) | 1.2 | $148M | 3.9M | 37.98 | |
| Alibaba Group Holding (BABA) | 1.2 | $144M | 1.1M | 137.07 | |
| Liberty Global Inc Com Ser A | 1.1 | $128M | 6.0M | 21.34 | |
| Tesaro | 1.0 | $126M | 1.7M | 74.25 | |
| Arris | 0.9 | $109M | 3.6M | 30.57 | |
| Liberty Global Inc C | 0.8 | $102M | 4.9M | 20.64 | |
| Ascendis Pharma A S (ASND) | 0.8 | $94M | 1.5M | 62.65 | |
| Acceleron Pharma | 0.8 | $92M | 2.1M | 43.55 | |
| Array BioPharma | 0.7 | $82M | 5.8M | 14.25 | |
| Myokardia | 0.6 | $78M | 1.6M | 48.86 | |
| Pandora Media | 0.6 | $75M | 9.2M | 8.09 | |
| Zogenix | 0.6 | $75M | 2.1M | 36.46 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $70M | 640k | 109.13 | |
| Enanta Pharmaceuticals (ENTA) | 0.5 | $66M | 925k | 70.83 | |
| CVS Caremark Corporation (CVS) | 0.5 | $61M | 930k | 65.52 | |
| Global Blood Therapeutics In | 0.5 | $60M | 1.5M | 41.05 | |
| Mirati Therapeutics | 0.5 | $55M | 1.3M | 42.42 | |
| Iovance Biotherapeutics (IOVA) | 0.4 | $51M | 5.7M | 8.85 | |
| Amarin Corporation (AMRN) | 0.4 | $48M | 3.5M | 13.61 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.4 | $44M | 2.4M | 18.36 | |
| Novocure Ltd ord (NVCR) | 0.3 | $42M | 1.3M | 33.48 | |
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $40M | 550k | 72.91 | |
| Exelixis (EXEL) | 0.3 | $39M | 2.0M | 19.67 | |
| Nxp Semiconductors N V (NXPI) | 0.3 | $39M | 535k | 73.28 | |
| Reata Pharmaceuticals Inc Cl A | 0.3 | $39M | 700k | 56.10 | |
| Sage Therapeutics (SAGE) | 0.3 | $38M | 400k | 95.79 | |
| Crispr Therapeutics (CRSP) | 0.3 | $36M | 1.3M | 28.57 | |
| Radius Health | 0.3 | $34M | 2.0M | 16.49 | |
| Fibrogen (FGEN) | 0.3 | $35M | 750k | 46.28 | |
| Brookfield Ppty Partners L P unit ltd partn | 0.3 | $33M | 2.1M | 16.12 | |
| Orbotech Ltd Com Stk | 0.2 | $30M | 536k | 56.54 | |
| Ready Cap Corp Com reit (RC) | 0.2 | $31M | 2.2M | 13.83 | |
| Fate Therapeutics (FATE) | 0.2 | $28M | 2.2M | 12.83 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $24M | 700k | 34.32 | |
| Ptc Therapeutics Inc conv bd us | 0.2 | $24M | 24M | 0.98 | |
| Zymeworks | 0.2 | $23M | 1.6M | 14.68 | |
| Codexis (CDXS) | 0.2 | $19M | 1.2M | 16.70 | |
| Anheuser-Busch InBev NV (BUD) | 0.1 | $18M | 276k | 65.81 | |
| Clovis Oncology | 0.1 | $18M | 1.0M | 17.96 | |
| Dynavax Technologies (DVAX) | 0.1 | $18M | 2.0M | 9.15 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $19M | 1.5M | 12.42 | |
| Savara (SVRA) | 0.1 | $18M | 2.4M | 7.57 | |
| Progenics Pharmaceuticals | 0.1 | $18M | 4.2M | 4.20 | |
| Chemocentryx | 0.1 | $16M | 1.5M | 10.91 | |
| Bemis Company | 0.1 | $15M | 316k | 45.90 | |
| Shire | 0.1 | $15M | 87k | 174.76 | |
| Quotient | 0.1 | $15M | 2.4M | 6.12 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $15M | 2.2M | 6.73 | |
| Industrial Logistics pfds, reits (ILPT) | 0.1 | $12M | 611k | 19.67 | |
| Zealand Pharma A/s- | 0.1 | $10M | 900k | 11.61 | |
| Aptinyx | 0.1 | $11M | 670k | 16.54 | |
| Avrobio Ord (AVRO) | 0.1 | $11M | 650k | 16.65 | |
| Clovis Oncology Inc note 1.250% 5/0 | 0.1 | $11M | 15M | 0.71 | |
| Principia Biopharma | 0.1 | $9.6M | 350k | 27.39 | |
| Mellanox Technologies | 0.1 | $8.8M | 95k | 92.38 | |
| Zafgen | 0.1 | $8.8M | 1.8M | 4.95 | |
| Voyager Therapeutics (VYGR) | 0.1 | $8.5M | 909k | 9.40 | |
| Voya Financial (VOYA) | 0.1 | $7.4M | 185k | 40.14 | |
| Assembly Biosciences | 0.1 | $7.9M | 350k | 22.62 | |
| Synthorx | 0.1 | $6.7M | 386k | 17.38 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $3.3M | 6.8M | 0.48 | |
| Translate Bio | 0.0 | $3.8M | 500k | 7.50 | |
| Avista Corporation (AVA) | 0.0 | $2.7M | 63k | 42.48 | |
| Intra Cellular Therapies (ITCI) | 0.0 | $2.8M | 250k | 11.39 | |
| Pfenex | 0.0 | $1.9M | 600k | 3.19 | |
| Bellicum Pharma | 0.0 | $2.9M | 1.0M | 2.92 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $2.9M | 95k | 29.99 | |
| Tyme Technologies | 0.0 | $1.1M | 301k | 3.69 | |
| Ra Med Sys | 0.0 | $305k | 38k | 7.96 |
